118 related articles for article (PubMed ID: 579063)
1. The pharmacology of a new potent, long acting neuroleptic, piflutixol.
Nielsen IM; Boeck V; Christensen AV; Danneskiold-Samsoe P; Hyttel J; Langeland J; Pedersen V; Svendsen O
Acta Pharmacol Toxicol (Copenh); 1977 Oct; 41(4):369-83. PubMed ID: 579063
[TBL] [Abstract][Full Text] [Related]
2. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
Christensen AV; Arnt J; Hyttel J; Svendsen O
Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of neuroleptics upon repeated administration.
Moller Nielsen I; Fjalland B; Pedersen V; Nymark M
Psychopharmacologia; 1974 Jan; 34(2):95-104. PubMed ID: 4856370
[No Abstract] [Full Text] [Related]
4. Effect of piflutixol on turnover of catecholamines in mouse brain and rat corpus striatum.
Hyttel J
Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):449-57. PubMed ID: 579556
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of cis(Z)-clopenthixol decanoate, a depot neuroleptic.
Pedersen V; Svendsen O; Danneskiold-Samsoe P; Boeck V; Nielsen IM
Acta Pharmacol Toxicol (Copenh); 1977 Apr; 40(4):482-90. PubMed ID: 577108
[TBL] [Abstract][Full Text] [Related]
6. The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug.
Voith K; Herr F
Psychopharmacologia; 1975 Apr; 42(1):11-20. PubMed ID: 1171496
[TBL] [Abstract][Full Text] [Related]
7. The relationship between the occupation of the D-1 dopamine receptor by [3H]piflutixol and the activity of dopamine-sensitive adenylate cyclase in rat striatal membranes.
Fleminger S
Biochem Pharmacol; 1991 Jul; 42(2):229-37. PubMed ID: 1650205
[TBL] [Abstract][Full Text] [Related]
8. Influence of flupenthixol and flupenthixol-decanoate on methylphenidate and apomorphine-induced compulsive gnawing in mice.
Christensen AV; Moller Nielsen I
Psychopharmacologia; 1974 Jan; 34(2):119-26. PubMed ID: 4856369
[No Abstract] [Full Text] [Related]
9. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Wauquier A
Arzneimittelforschung; 1975 Aug; 25(8):1287-94. PubMed ID: 1242360
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers.
Arnt J; Bøgesø KP; Christensen AV; Hyttel J; Larsen JJ; Svendsen O
Psychopharmacology (Berl); 1983; 81(3):199-207. PubMed ID: 6139838
[TBL] [Abstract][Full Text] [Related]
11. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
[No Abstract] [Full Text] [Related]
12. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
[TBL] [Abstract][Full Text] [Related]
13. [Neurotropic properties of fluphenazine].
Liubimov BI; Raevskiĭ KS; Ostrovskaia RU; Barkov NK; Krolevets GN
Farmakol Toksikol; 1971; 34(3):287-90. PubMed ID: 5106035
[No Abstract] [Full Text] [Related]
14. Pharmacological properties of new neuroleptic compounds.
Coscia L; Causa P; Giuliani E; Nunziata A
Arzneimittelforschung; 1975 Sep; 25(9):1436-42. PubMed ID: 25
[TBL] [Abstract][Full Text] [Related]
15. Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
Murugaiah K; Fleminger S; Hall MD; Theodorou A; Jenner P; Marsden CD
Neuropharmacology; 1984 Jun; 23(6):599-609. PubMed ID: 6540376
[TBL] [Abstract][Full Text] [Related]
16. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Khisti RT; Deshpande LS; Chopde CT
Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
[TBL] [Abstract][Full Text] [Related]
17. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
18. The neuroleptics. 3. Pharmacology. Introduction.
Van Rossum JM; Janssen PA; Boissier JR; Julou L; Loew DM; Moller Nielsen I; Munkvad I; Randrup A; Stille G; Tedeschi DH
Mod Probl Pharmacopsychiatry; 1970; 5():23-32. PubMed ID: 5527165
[No Abstract] [Full Text] [Related]
19. Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat.
Fleminger S; van de Waterbeemd H; Rupniak NM; Reavill C; Testa B; Jenner P; Marsden CD
J Pharm Pharmacol; 1983 Jun; 35(6):363-8. PubMed ID: 6135774
[TBL] [Abstract][Full Text] [Related]
20. Analogs of phenothiazines. 6. Stereochemical assignment of isomeric aminoalkylidene derivatives of xanthenes and thioxanthenes with neuropharmacological activity.
Kaiser C; Warren RJ; Zirkle CL
J Med Chem; 1974 Jan; 17(1):131-3. PubMed ID: 4808461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
